SALUBRIS
Live / Registered — Registered (as of 07 Jan 2020)
What this means for you
Registered since 07 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88133406
- Registration number
- 5952886
- Mark type
- Stylized text
- Filed
- 26 Sept 2018
- Published for opposition
- 22 Oct 2019
- Registered
- 07 Jan 2020
- Attorney of record
- Timothy T. Wang
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system; Pharmaceutical preparations for use in treating cancerous tumors; Pharmaceutical preparations for use in treating metabolic diseases and diseases of the immune system and the musculo-skeletal system; Chemical preparations for pharmaceutical or medical purposes, namely, Pharmaceutical preparations for use in haematology, dermatology, ophthalmology and gastroenterology, Pharmaceutical preparations being anti-infectives, Pharmaceutical preparations for use in treating diseases of the respiratory system, the digestive system, and the endocrine system, Pharmaceutical preparations for use in treating hypersensitivity diseases; Medicines for human purpose for treating disease, namely, pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system, pharmaceutical preparations for use in treating cancerous tumors, pharmaceutical preparations for use in treating metabolic diseases, as well as diseases of the immune system and the musculo-skeletal system; Active pharmaceutical ingredients in the nature of pharmaceutical preparations used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, and the musculo-skeletal system, and for treating cancerous tumors; Biochemical medicines for use in treating diseases of the cardiovascular system and cerebrovascular system; Biochemical medicines for use in treating cancerous tumors; Biochemical medicines for use in treating metabolic diseases, nervous system diseases as well as diseases of the immune system and the musculo-skeletal system; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the metabolic system, the respiratory system, and the musculo-skeletal system, pharmaceutical preparations for use in tissue and organ transplantation, for use in ophthalmology and for use in treatment of gastroenterological disorders
Owner
- SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD., Shenzhen, Guangdong Pr, CN
- SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD., Shenzhen, Guangdong Pr, CN
- SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD., Shenzhen, Guangdong Pr, CN
Prosecution history
- 07 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 22 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2019 — PUBLISHED FOR OPPOSITION
- 02 Oct 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Sept 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Aug 2019 — EXAMINER'S AMENDMENT ENTERED
- 09 Aug 2019 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 09 Aug 2019 — EXAMINERS AMENDMENT E-MAILED
- 09 Aug 2019 — EXAMINERS AMENDMENT -WRITTEN
- 07 Aug 2019 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 06 Aug 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Aug 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Aug 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 Aug 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED